Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amir Onn

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Clinical Lung Cancer|December 14, 2011
Overcoming molecular mechanisms of resistance to first-generation epidermal growth factor receptor tyrosine kinase inhibitorsJair Bar, Amir Onn
Expert Opinion on Pharmacotherapy|March 19, 2008
Combined anti-proliferative and anti-angiogenic strategies for cancerJair Bar, Amir Onn
In Vivo (Athens, Greece)|December 24, 2002
Metastatic potential of human neoplasmsAmir Onn, Isaiah J Fidler
Harefuah|July 27, 2013
[Tissue repositories for research at Sheba Medical Center(SMC]Yehudit Cohen, Iris Barshack, Amir Onn
Clinical Lung Cancer|May 8, 2009
Multitargeted inhibitors in lung cancer: new clinical dataJair Bar, Roy S Herbst, Amir Onn
Seminars in Oncology|July 1, 2005
Current management of advanced non-small cell lung cancer: targeted therapyTakeshi Isobe, Roy S Herbst, Amir Onn
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2018
Tumor-Infiltrating Lymphocytes-Location for Prognostic EvaluationMichael Peled, Amir Onn, Roy S Herbst
Expert Opinion on Drug Delivery|August 12, 2009
Targeted drug delivery strategies to treat lung metastasisJair Bar, Roy S Herbst, Amir Onn
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2005
Angiogenesis and lung cancer: prognostic and therapeutic implicationsRoy S Herbst, Amir Onn, Alan Sandler
American Journal of Surgery|February 11, 2005
Weight loss and improvement of obesity-related illness in 500 U.S. patients following laparoscopic adjustable gastric banding procedureHadar Spivak, Mary F Hewitt, Amir Onn, et al.
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Clinical Lung Cancer|December 14, 2011
Overcoming molecular mechanisms of resistance to first-generation epidermal growth factor receptor tyrosine kinase inhibitorsJair Bar, Amir Onn
Expert Opinion on Pharmacotherapy|March 19, 2008
Combined anti-proliferative and anti-angiogenic strategies for cancerJair Bar, Amir Onn
In Vivo (Athens, Greece)|December 24, 2002
Metastatic potential of human neoplasmsAmir Onn, Isaiah J Fidler
Harefuah|July 27, 2013
[Tissue repositories for research at Sheba Medical Center(SMC]Yehudit Cohen, Iris Barshack, Amir Onn
Clinical Lung Cancer|May 8, 2009
Multitargeted inhibitors in lung cancer: new clinical dataJair Bar, Roy S Herbst, Amir Onn
Seminars in Oncology|July 1, 2005
Current management of advanced non-small cell lung cancer: targeted therapyTakeshi Isobe, Roy S Herbst, Amir Onn
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2018
Tumor-Infiltrating Lymphocytes-Location for Prognostic EvaluationMichael Peled, Amir Onn, Roy S Herbst
Expert Opinion on Drug Delivery|August 12, 2009
Targeted drug delivery strategies to treat lung metastasisJair Bar, Roy S Herbst, Amir Onn
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2005
Angiogenesis and lung cancer: prognostic and therapeutic implicationsRoy S Herbst, Amir Onn, Alan Sandler
American Journal of Surgery|February 11, 2005
Weight loss and improvement of obesity-related illness in 500 U.S. patients following laparoscopic adjustable gastric banding procedureHadar Spivak, Mary F Hewitt, Amir Onn, et al.
Pageof 10